Emma L Frazier1, Madeline Y Sutton1, Yunfeng Tie1,2, A D McNaghten1,3, Janet M Blair1, Jacek Skarbinski1. 1. 1 Division of HIV/AIDS Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention, Centers for Disease Control and Prevention , Atlanta, Georgia . 2. 2 ICF International , Atlanta, GA. 3. 3 Rollins School of Public Health, Emory University , Atlanta, Georgia .
Abstract
BACKGROUND: Women living with HIV infection are at higher risk for cervical cancer, an AIDS-defining diagnosis. We examined the prevalence of cervical cancer and sexually transmitted disease (STD) screening among human immunodeficiency virus (HIV)-infected women and factors associated with the receipt of Papanicolaou (Pap) tests. METHODS: We did a cross-sectional analysis of weighted data from a sample of HIV-infected adults receiving outpatient medical care. We used matched interview (report of Pap test) and medical record data (STD screenings) from HIV-infected women. We performed logistic regression to compute adjusted prevalence ratios and 95% confidence intervals for the association between demographic, behavioral, and clinical factors and receipt of Pap tests among HIV-infected women. RESULTS: Data were available for 2,270 women, who represent 112,894 HIV-infected women; 62% were African American, 17% were Hispanic/Latina, and 18% were white. Most (78%) reported having a Pap test in the past year. Among sexually active women (n = 1234), 20% reported sex without condoms, 27% were screened for gonorrhea, and 29% were screened for chlamydia. Being screened for STDs was less likely among women who did not have a Pap test in the past year (adjusted prevalence ratios 0.82, 95% confidence interval 0.77-0.87). Women who were ≥50 years of age and reported income above federal poverty level, no sexual activity, depression, no HIV care from an obstetrician/gynecologist, and no documented STD tests, were less likely to report a Pap test (p < 0.05). CONCLUSIONS: Screening for cervical cancer and STDs among HIV-infected women is suboptimal. Clinical visits for Pap tests are an important opportunity for HIV-infected sexually active women to also receive STD screenings and counseling regarding condoms.
BACKGROUND:Women living with HIV infection are at higher risk for cervical cancer, an AIDS-defining diagnosis. We examined the prevalence of cervical cancer and sexually transmitted disease (STD) screening among humanimmunodeficiency virus (HIV)-infectedwomen and factors associated with the receipt of Papanicolaou (Pap) tests. METHODS: We did a cross-sectional analysis of weighted data from a sample of HIV-infected adults receiving outpatient medical care. We used matched interview (report of Pap test) and medical record data (STD screenings) from HIV-infectedwomen. We performed logistic regression to compute adjusted prevalence ratios and 95% confidence intervals for the association between demographic, behavioral, and clinical factors and receipt of Pap tests among HIV-infectedwomen. RESULTS: Data were available for 2,270 women, who represent 112,894 HIV-infectedwomen; 62% were African American, 17% were Hispanic/Latina, and 18% were white. Most (78%) reported having a Pap test in the past year. Among sexually active women (n = 1234), 20% reported sex without condoms, 27% were screened for gonorrhea, and 29% were screened for chlamydia. Being screened for STDs was less likely among women who did not have a Pap test in the past year (adjusted prevalence ratios 0.82, 95% confidence interval 0.77-0.87). Women who were ≥50 years of age and reported income above federal poverty level, no sexual activity, depression, no HIV care from an obstetrician/gynecologist, and no documented STD tests, were less likely to report a Pap test (p < 0.05). CONCLUSIONS: Screening for cervical cancer and STDs among HIV-infectedwomen is suboptimal. Clinical visits for Pap tests are an important opportunity for HIV-infected sexually active women to also receive STD screenings and counseling regarding condoms.
Authors: Amy S Baranoski; C Robert Horsburgh; L Adrienne Cupples; Ann Aschengrau; Elizabeth A Stier Journal: J Womens Health (Larchmt) Date: 2011-08-31 Impact factor: 2.681
Authors: Arti Barnes; Andrea C Betts; Eric K Borton; Joanne M Sanders; Sandi L Pruitt; Claudia Werner; Andres Bran; Carolee D Estelle; Bijal A Balasubramanian; Stephen J Inrig; Ethan A Halm; Celette Sugg Skinner; Jasmin A Tiro Journal: AIDS Date: 2018-08-24 Impact factor: 4.177
Authors: Manuela Viviano; Pierre DeBeaudrap; Pierre-Marie Tebeu; Jovanny T Fouogue; Pierre Vassilakos; Patrick Petignat Journal: Int J Womens Health Date: 2017-02-02
Authors: A P Ortiz; V Tamayo; A Scorsone; M Soto-Salgado; I Febo; P Piovanetti; H L Venegas-Ríos; Y Yamamura; C Zorrilla Journal: Papillomavirus Res Date: 2017-06-19
Authors: Najjuka Sarah Maria; Connie Olwit; Mark Mohan Kaggwa; Rose Chalo Nabirye; Tom Denis Ngabirano Journal: BMC Womens Health Date: 2022-05-10 Impact factor: 2.742